Safety and efficacy of sofosbuvir-based direct-acting antiviral regimens for hepatitis C virus genotype 6 in Southwest China: Real-world experience of a retrospective study-Reference-Cited by-同舟云学术

Safety and efficacy of sofosbuvir-based direct-acting antiviral regimens for hepatitis C virus genotype 6 in Southwest China: Real-world experience of a retrospective study

Published:2018-12-03 Issue:3 Volume:26 Page:316-322
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Wu Dong-Bo¹,Jiang Wei¹,Wang Yong-Hong¹,Chen Bin¹,Wang Meng-Lan¹,Tao Ya-Chao¹,Chen En-Qiang¹^ORCID,Tang Hong¹

Affiliation:

1. Center of Infectious Diseases; West China Hospital, Sichuan University; Chengdu China

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.13033/fullpdf

Reference32 articles.

1. EASL recommendations on treatment of hepatitis C 2016;J Hepatol,2017

2. WHO Guidelines Approved by the Guidelines Review Committee Guidelines for the Screening Care and Treatment of Persons with Chronic Hepatitis C Infection: Updated Version Geneva World Health Organization 2016

3. WHO Guidelines Approved by the Guidelines Review Committee WHO Guidelines on Hepatitis B and C Testing Geneva World Health Organization 2017

4. Progress report on access to hepatitis C treatment: focus on overcoming barriers in low- and middle-income countries World Health Organization 2018 http://www.who.int/hepatitis/publications/hep-c-access-report-2018/en/

5. Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection;Feld;N Engl J Med,2015

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024;Saudi Journal of Gastroenterology;2024-01

2. Assessment of hepatic fibrosis, portal hemodynamic changes, and disease severity in patients with HCV-related liver cirrhosis after sustained virologic response to direct-acting antiviral drugs (DAAs);Egyptian Liver Journal;2023-10-02

3. High Cure Rates for Hepatitis C Virus Genotype 6 in Advanced Liver Fibrosis With 12 Weeks Sofosbuvir and Daclatasvir: The Vietnam SEARCH Study;Open Forum Infectious Diseases;2021-06-09

4. Sofosbuvir-Based Therapies Achieved Satisfactory Virological Response in Chinese Individuals with Genotypes 3 and 6 Infections: A Real-World Experience;Infection and Drug Resistance;2021-06

5. Cost-effectiveness of new antiviral treatments for non-genotype 1 hepatitis C virus infection in China: a societal perspective;BMJ Global Health;2020-11